Literature DB >> 12207790

Ulcerative terminal ileitis after BCG therapy for bladder carcinoma.

D Satgé1, I Pommepuy, T Hassan, J Goburdhun, J-F Flejou.   

Abstract

AIM: We evaluated the aetiology of ulcerative ileitis in a 77-year-old patient receiving BCG therapy for recurring bladder carcinoma. METHODS AND
RESULTS: Histological examination, laboratory data and the clinical history allowed us to exclude a classical cause such as Crohn's disease, tuberculosis or ischaemia. The important locoregional reaction suggests a BCG ileitis of the terminal ileum. Intestinal BCG ileitis has been exceptionally described after BCG vaccination.
CONCLUSION: Our observation of ulcerative ileitis indicates that a digestive tract location is possible as a reaction to BCG therapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12207790     DOI: 10.1046/j.1365-2559.2002.01445.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  2 in total

1.  Gastrointestinal Crohn-like disease following BCG therapy.

Authors:  Marco Pizzi; Laura Albertoni; Lavinia Stefanizzi; Claudia Mescoli; Massimo Rugge
Journal:  Int J Colorectal Dis       Date:  2015-02-18       Impact factor: 2.571

Review 2.  Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.

Authors:  María Asunción Pérez-Jacoiste Asín; Mario Fernández-Ruiz; Francisco López-Medrano; Carlos Lumbreras; Ángel Tejido; Rafael San Juan; Ana Arrebola-Pajares; Manuel Lizasoain; Santiago Prieto; José María Aguado
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.